It is far less expensive and three times more effective than mammography technology that detects breast cancer. The MBI (molecular breast imaging) co-inventor and advocate says she will see no financial gain from its use; yet its low-cost seems to be exactly what stands in the way of it getting recognition, let alone adoption. Dr. Deborah Rhodes explains at TED how political and economic influences affect risk management and innovation in American health care: